6533b873fe1ef96bd12d551e

RESEARCH PRODUCT

P2.04-11 An IL-8/IFN-gammma/NLR Plasma Score to Predict Nivolumab Efficacy in Patients with NSCLC

A. RussoVeronica HuberH. Soto ParraL. LalliFrancesco PassigliaLicia RivoltiniAgata CovaS. Ferro

subject

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMedicineIn patientInterleukin 8Nivolumabbusinesshttps://doi.org/10.1016/j.jtho.2018.08.1235